HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Decreased by MassMutual Private Wealth & Trust FSB

MassMutual Private Wealth & Trust FSB decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 10.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 376 shares of the company’s stock after selling 45 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in HCA Healthcare were worth $113,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of HCA. Clarius Group LLC increased its position in HCA Healthcare by 19.1% in the 4th quarter. Clarius Group LLC now owns 1,540 shares of the company’s stock worth $462,000 after purchasing an additional 247 shares during the last quarter. Arkadios Wealth Advisors raised its position in HCA Healthcare by 46.9% during the fourth quarter. Arkadios Wealth Advisors now owns 3,435 shares of the company’s stock valued at $1,031,000 after acquiring an additional 1,096 shares in the last quarter. Canoe Financial LP raised its holdings in shares of HCA Healthcare by 226,952.9% during the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after purchasing an additional 231,492 shares in the last quarter. Merit Financial Group LLC increased its position in HCA Healthcare by 137.7% during the fourth quarter. Merit Financial Group LLC now owns 1,569 shares of the company’s stock worth $471,000 after buying an additional 909 shares during the last quarter. Finally, Wedge Capital Management L L P NC boosted its stake in shares of HCA Healthcare by 7.7% during the 4th quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company’s stock worth $34,840,000 after acquiring an additional 8,329 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $325.18 on Friday. The stock has a market capitalization of $82.37 billion, a price-to-earnings ratio of 14.60, a P/E/G ratio of 1.08 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14. The firm’s 50-day moving average price is $314.50 and its two-hundred day moving average price is $352.84.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.